eXmoor Pharma, a UK-based contract development and manufacturing organization (CDMO) specializing in cell and gene therapies, has entered a strategic partnership with Anthony Nolan Cell Therapy & Laboratory Services (CT&LS), a leader in cellular starting materials, to provide an integrated solution for cell therapy developers. The collaboration combines eXmoor’s manufacturing expertise with Anthony Nolan’s donor sourcing and apheresis capabilities, aiming to streamline the development of autologous and allogeneic cell therapies.

The partnership offers an end-to-end service, covering donor recruitment, screening, apheresis collection, process development, and good manufacturing practice (GMP) production. By aligning their complementary strengths, the two organizations seek to support clients in navigating the complex journey from starting material to clinical supply while prioritizing patient and donor welfare.

Read the full article.